PMID: 42493207

Semaglutide for prevention of type 2 diabetes in women with postpartum prediabetes after gestational diabetes: protocol for a Belgian multicentre double-blind randomised placebo-controlled trial.

Vanlaer Yana, Embo Nina, Bochanen Niels, Van Wilder Nancy, Vereecke Gertjan, Wierckx Katrien, Verhaegen Ann, Coremans Peter, Philips Jean-Christophe, Lytrivi Maria

BMJ open · 2026

Vol. 16, Issue 7, pp. e118191

This entry links to third-party literature. For research use only.